Table 1.
Comparison of demographic features between non-DVT and concomitant DVT in patients with PE
| Demographic features | All patients (n=141) | Non-DVT (n=77, 54.6%) | Concomitant DVT (n=64, 45.4%) | P-valuea |
|---|---|---|---|---|
| Age (y) | 69.90±15.13 | 71.05±14.02 | 68.52±16.36 | 0.616 |
| <50 | 16 (11.3) | 7 (9.1) | 9 (14.1) | |
| 51–69 | 38 (27.0) | 21 (27.3) | 17 (26.5) | 0.647 |
| ≥70 | 87 (61.7) | 49 (63.6) | 38 (59.4) | |
| Male | 65 (46.1) | 37 (48.1) | 28 (43.8) | 0.610 |
| PE-related risk factors | ||||
| PE-related symptoms | 87 (61.7) | 51 (66.2) | 36 (56.3) | 0.225 |
| HR >100/min | 51 (36.2) | 26 (33.8) | 25 (39.1) | 0.515 |
| Respiration rate >30/min | 9 (6.4) | 4 (5.2) | 5 (7.8) | 0.732 |
| SpO2 <90% | 41 (29.1) | 21 (27.3) | 20 (31.3) | 0.605 |
| Risk factor for VTE | ||||
| History of VTE | 15 (10.6) | 6 (7.8) | 9 (14.1) | 0.229 |
| Immobilization ≥3 days | 61 (43.3) | 29 (37.7) | 32 (50.0) | 0.141 |
| History of surgery or trauma ≤4 weeks | 21 (14.9) | 11 (14.3) | 10 (15.6) | 0.824 |
| Active malignancy and/or chemotherapy | 39 (27.7) | 20 (26.0) | 19 (29.7) | 0.624 |
| Comorbidities | ||||
| HTN | 80 (56.7) | 42 (54.5) | 38 (59.4) | 0.564 |
| DM | 44 (31.2) | 29 (37.7) | 15 (23.4) | 0.070 |
| CAD | 10 (7.1) | 7 (9.1) | 3 (4.7) | 0.348 |
| Chronic kidney disease | 5 (3.5) | 3 (3.9) | 2 (3.1) | 1.000 |
| Congestive heart failure | 12 (8.5) | 8 (10.4) | 4 (6.3) | 0.547 |
| CVA | 30 (21.3) | 16 (20.8) | 14 (21.9) | 0.874 |
| Dementia | 10 (7.1) | 3 (3.9) | 7 (10.9) | 0.185 |
| Underlying pulmonary disease | 52 (36.9) | 28 (36.4) | 24 (37.5) | 0.889 |
| Smoking | 11 (7.8) | 7 (9.1) | 4 (6.3) | 0.754 |
| Location of PE | ||||
| Main & lobar arteries | 86 (61.0) | 42 (54.5) | 44 (68.8) | 0.085 |
| Segmental & subsegmental arteries | 55 (39.0) | 35 (63.6) | 20 (36.4) | |
| Anticoagulation treatment | 122 (86.5) | 67 (87.0) | 55 (85.9) | 0.852 |
| PE-related unfavorable outcome | 25 (17.7) | 11 (14.3) | 14 (21.9) | 0.240 |
| 30-day all-cause mortality | 28 (19.9) | 14 (18.2) | 14 (21.9) | 0.584 |
Values are presented as mean±standard deviation or number (%).
DVT, deep venous thrombosis; PE, pulmonary embolism; HR, heart rate; SpO2, peripheral oxygen saturation; VTE, venous thromboembolism; HTN, hypertension; DM, diabetes mellitus; CAD, coronary artery disease; CVA, cerebrovascular accident.
a
Chi-square test or Fisher’s exact test.